
Please try another search
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and pediatric drug-resistant epilepsies; and OV350, a small molecule direct activator of the KCC2 transporter, which is in Phase 1 clinical trials for treating epilepsies. It develops OV350 IV, OV4071, and OV4041, an oral program that behave similarly in phenotypical screens for the treatment of psychosis in people with NSD and LBD; and OV888 (GV101), a highly selective rock2 inhibitor which is in Phase 1 double-blind multiple-ascending dose trial. The company has license and collaboration agreements with Healx, AstraZeneca AB, H. Lundbeck A/S, Northwestern University, and Graviton, as well as Marinus Pharmaceuticals, Inc. The company was incorporated in 2014 and is headquartered in New York, New York.
Name | Age | Since | Title |
---|---|---|---|
Jeremy Max Levin | 72 | 2014 | CEO & Chairman |
Jamie Maguire | - | 2024 | Member of Scientific Advisory Board |
Karen Bernstein | 72 | 2015 | Independent Director |
Bart Friedman | 80 | 2015 | Lead Independent Director |
Barbara G. Duncan | 60 | 2017 | Independent Director |
Robert S. Langer | 76 | 2021 | Chairman of the Scientific & Clinical Advisory Board |
Kevin Joseph Fitzgerald | 56 | 2021 | Independent Director |
Isam Awad | - | 2024 | Member of Scientific Advisory Board |
Raman Sankar | - | 2024 | Member of Scientific Advisory Board |
Imad Najm | - | 2024 | Member of Scientific Advisory Board |
Jacqueline A. French | - | 2017 | Member of Scientific & Clinical Advisory Board |
Jeffrey L. Noebels | - | 2024 | Member of Scientific Advisory Board |
Stelios Papadopoulos | 77 | 2025 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review